The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls

BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with obesity and increased cardiovascular (CV) risk markers. In this study our aim was to assess the effects of six months treatment with liraglutide 1.8 mg od on obesity, and CV risk markers, particularly platelet function, in young obese w...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Endocr Disord
Egile Nagusiak: Kahal, Hassan, Aburima, Ahmed, Ungvari, Tamas, Rigby, Alan S, Coady, Anne M, Vince, Rebecca V, Ajjan, Ramzi A, Kilpatrick, Eric S, Naseem, Khalid M, Atkin, Stephen L
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4389314/
https://ncbi.nlm.nih.gov/pubmed/25880805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-015-0005-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak